Simplex Trading’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-49,959
Closed -$373K 10233
2025
Q3
$155K Sell
49,959
-78,945
-61% -$209K ﹤0.01% 5241
2025
Q2
$275K Buy
128,904
+126,391
+5,029% +$204K ﹤0.01% 4182
2025
Q1
$2K Sell
2,513
-147,041
-98% -$252K ﹤0.01% 8103
2024
Q4
$327K Buy
+149,554
New +$339K ﹤0.01% 3981
2024
Q3
Sell
-12,482
Closed -$28.7K 9693
2024
Q2
$28K Sell
12,482
-562
-4% -$2.33K ﹤0.01% 6619
2024
Q1
$71K Buy
13,044
+941
+8% +$4.3K ﹤0.01% 5944
2023
Q4
$29K Buy
+12,103
New +$115K ﹤0.01% 6605

Other funds holding VTYX

Simplex Trading's VTYX Position: Q4 2025 in Review

Simplex Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 49,959 shares — an estimated $373K sold.

Simplex Trading first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $327K in Q4 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Simplex Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 49,959 Ventyx Biosciences shares in Q4 2025, an estimated $373K.
  • Simplex Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
  • Simplex Trading's Ventyx Biosciences position peaked at $327K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.